A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitis.
about
Safety, effectiveness, and pharmacokinetics of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to 4 years.Clinical characteristics of Japanese patients with axial spondyloarthritis, and short-term efficacy of adalimumab.A multicenter, open-label, long-term study of three-year infliximab administration in Japanese patients with ankylosing spondylitis.
P2860
A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
A multicenter, open-label, eff ...... s with ankylosing spondylitis.
@ast
A multicenter, open-label, eff ...... s with ankylosing spondylitis.
@en
type
label
A multicenter, open-label, eff ...... s with ankylosing spondylitis.
@ast
A multicenter, open-label, eff ...... s with ankylosing spondylitis.
@en
prefLabel
A multicenter, open-label, eff ...... s with ankylosing spondylitis.
@ast
A multicenter, open-label, eff ...... s with ankylosing spondylitis.
@en
P2093
P2860
P1433
P1476
A multicenter, open-label, eff ...... s with ankylosing spondylitis.
@en
P2093
Aileen L Pangan
L Steven Brown
Masayoshi Harigai
Neelufar Mozaffarian
Nobuyuki Miyasaka
Shigeto Kobayashi
Shringi Sharma
P2860
P304
P356
10.3109/S10165-011-0557-X
P577
2011-12-29T00:00:00Z